Exact Sciences
Overview
Exact Sciences Corp. is a molecular diagnostic company specializing in the detection of early-stage cancers . The company's initial focus was on early detection and prevention of colorectal cancer; its stool DNA test, Cologuard, was launched in 2014 . Exact Sciences also offers Oncotype DX gene expression tests for prostate, breast, and colon cancers .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| KeyCare | Mar 2026 | Early Funding | Co-investor |
For institutional investors. Book with your work email.
Key People
Ryan McWaters
Director, Revenue Improvement
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Exact Sciences based?
Exact Sciences is headquartered in Madison, Wisconsin, United States.
When was Exact Sciences founded?
Exact Sciences was founded in 1995.
How many portfolio companies does Exact Sciences have?
Exact Sciences has 3 portfolio companies in Caplight's dataset.
What are some companies in Exact Sciences's portfolio?
Portfolio companies visible on Caplight include KeyCare.
What was Exact Sciences's most recent investment shown here?
Exact Sciences's most recent investment in this portfolio sample was in KeyCare in 2026.
What sectors does Exact Sciences focus on?
Exact Sciences focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does Exact Sciences focus on?
Exact Sciences typically invests at the MultiStage stage.
What is Exact Sciences's AUM?
Exact Sciences's assets under management are estimated between $1.0B and $10.0B.